WEDNESDAY, Jan. 25, 2023 (HealthDay News) — Memory loss is the most common symptom associated with Alzheimer’s disease — the terrifying prospect of slowly forgetting yourself and everything around you. But people who exhibit memory loss early on in their dementia actually have a slower rate of decline than thoseContinue Reading

THURSDAY, Jan. 12, 2023 (HealthDay News) — American adults who have epilepsy and are Black or Hispanic are less likely than white adults to be prescribed the latest medications, according to new research. “While finding the right medication is often a trial-and-error process that is based on the individual, studiesContinue Reading

THURSDAY, Jan. 12, 2023 (HealthDay News) — Six minutes of high-intensity exercise might prolong the lifespan of a healthy brain, perhaps delaying the start of Alzheimer’s and Parkinson’s diseases, a new, small study suggests. Researchers found that short but intense cycling increased the production of a protein called brain-derived neurotrophicContinue Reading

FRIDAY, Jan. 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved a second Alzheimer’s drug, lecanemab, despite reports of rare brain bleeds linked to use of the drug in some patients. However, the FDA pointed to the drug’s benefits, as well. “Alzheimer’s disease immeasurably incapacitatesContinue Reading

THURSDAY, Jan. 5, 2023 (HealthDay News) — Lecanemab: It’s an experimental medication that’s been shown in trials to slow cognitive decline in people with Alzheimer’s disease. It’s also up for accelerated approval by the U.S. Food and Drug Administration, with a decision expected by Jan. 6. However, the drug hasContinue Reading